Results 1 to 10 of about 1,220,987 (370)

Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review.

open access: yesPLoS ONE, 2020
BACKGROUND:The data on infective endocarditis after transcatheter aortic valve implantation (TAVI) is scarce and limited to case reports and case series in the literature.
Adnan Khan   +3 more
doaj   +2 more sources

Challenges in Infective Endocarditis

open access: yesJournal of the American College of Cardiology, 2017
Infective endocarditis is defined by a focus of infection within the heart and is a feared disease across the field of cardiology. It is frequently acquired in the health care setting, and more than one-half of cases now occur in patients without known heart disease. Despite optimal care, mortality approaches 30% at 1 year.
Cahill, Thomas J.   +7 more
openaire   +5 more sources

Infective endocarditis [PDF]

open access: yesNature Reviews Disease Primers, 2016
Infective endocarditis (IE) is a rare, life-threatening disease that has long-lasting effects even among patients who survive and are cured. IE disproportionately affects those with underlying structural heart disease and is increasingly associated with health care contact, particularly in patients who have intravascular prosthetic material.
Holland, Thomas   +5 more
  +11 more sources

Association of recurrent fever and anemia with infective endocarditis in a 13-year-old girl with bicuspid aortic valve [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2022
Introduction. Infective endocarditis is relatively rare in pediatric population, but can result in significant morbidity and mortality. Children with bicuspid aortic valve are at higher risk of developing infective endocarditis as compared to the general
Petrović Vesna   +2 more
doaj   +1 more source

Infective Endocarditis as the Cause of Death: A Population based Study in Portugal, from 2002 to 2018

open access: yesActa Médica Portuguesa, 2021
Introduction: Infective endocarditis presents a high rate of morbidity and mortality. Population-based studies addressing mortality caused by infective endocarditis in Portugal are scarce.
Catarina de Sousa   +2 more
doaj   +1 more source

The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.

open access: yesClinical Infectious Diseases, 2023
The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000.
V. Fowler   +24 more
semanticscholar   +1 more source

Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association

open access: yesCirculation, 2022
Background: The American Heart Association has sponsored both guidelines and scientific statements that address the diagnosis, management, and prevention of infective endocarditis.
L. Baddour   +8 more
semanticscholar   +1 more source

Infective endocarditis by HACEK: a review

open access: yesJournal of Cardiothoracic Surgery, 2022
Infective endocarditis (IE) is a severe disease that is still associated with high mortality despite recent advances in diagnosis and treatment.
Mansoor Khaledi   +6 more
semanticscholar   +1 more source

Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry

open access: yesEuropean Journal of Heart Failure, 2022
To evaluate the current management and survival of patients with left‐sided infective endocarditis (IE) complicated by congestive heart failure (CHF) in the ESC‐EORP European Endocarditis (EURO‐ENDO) registry.
Y. Bohbot   +17 more
semanticscholar   +1 more source

Infective Endocarditis in High-Income Countries

open access: yesMetabolites, 2022
Infective endocarditis remains an illness that carries a significant burden to healthcare resources. In recent times, there has been a shift from Streptococcus sp. to Staphylococcus sp. as the primary organism of interest.
F. Nappi   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy